MIRA Pharmaceuticals, Inc. Operating Lease, Weighted Average Discount Rate, Percent
MIRA Pharmaceuticals, Inc. (MIRA) had Operating Lease, Weighted Average Discount Rate, Percent of 5.00% as of 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2024-05-13
- 2024-03-31: Operating Lease, Weighted Average Discount Rate, Percent 5.00%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 5.00%.
- 2023-09-30: Operating Lease, Weighted Average Discount Rate, Percent 5.00%.
- 2023-06-30: Operating Lease, Weighted Average Discount Rate, Percent 5.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2024-03-31 | 5.00% 10-Q · filed 2024-05-13 |
| 2023-12-31 | 5.00% 10-K · filed 2024-04-01 |
| 2023-09-30 | 5.00% 10-Q · filed 2023-11-13 |
| 2023-06-30 | 5.00% 10-Q · filed 2023-09-15 |
| 2023-03-31 | 5.00% 10-Q · filed 2024-05-13 |
| 2022-12-31 | 5.00% 10-K · filed 2024-04-01 |
| 2022-09-30 | 5.00% 10-Q · filed 2023-11-13 |
| 2022-06-30 | 5.00% 10-Q · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |